Rob Ter Heine

38PUBLICATIONS
100CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyHaematologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Sep 06, 2026
Translational modelling challenges receptor‑occupancy‑based dosing of PD‑1 inhibitors like pembrolizumab.

|Aug 03, 2026
Dosing challenges for chemotherapy and immunotherapy in congenital achondroplasia: a case report and literature review.

|Jul 31, 2026
Population pharmacokinetics of total and free mycophenolic acid in plasma in paediatric patients with nephrotic syndrome including salivary concentrations and the pharmacodynamics.

|Jun 14, 2026
Exploring individualized crovalimab dosing in PNH through in silico modelling: Potential for improved convenience and cost efficiency.

|May 13, 2026
Deprescribing opportunities for patients with advanced non-small cell lung cancer: an observational study of potentially inappropriate medications and stakeholders' perspectives.

|Nov 06, 2025
Optimizing lazertinib therapy through GSTM1 genotyping: a strategy to reduce excess drug exposure and potential toxicity.

Rob Ter Heine, Bianca J C van den Bosch, Robin M van Geel

Pageof 7

Frequent Collaborators

6 joint publications

Roger J M Brüggemann

4 joint publications

Nikki de Rouw

4 joint publications

David M Burger

4 joint publications

Michel van den Heuvel